Your Cart ( 1 Item )

• Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis
  August 2026 | Volume 25 | Issue 8 | Original Article | 695 | Copyright © August 2026
  Brad R. Woodie BS^a*, Justin A. Freking BS^a*, Gabrielle M. Rivin MD^b, Alan B. Fleischer Jr MD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs